BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11574282)

  • 1. Gelatinase B: a tuner and amplifier of immune functions.
    Opdenakker G; Van den Steen PE; Van Damme J
    Trends Immunol; 2001 Oct; 22(10):571-9. PubMed ID: 11574282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
    Descamps FJ; Van den Steen PE; Nelissen I; Van Damme J; Opdenakker G
    Adv Exp Med Biol; 2003; 535():69-77. PubMed ID: 14714889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase B functions as regulator and effector in leukocyte biology.
    Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
    J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the roles of extracellular matrix remodeling by gelatinase B.
    Opdenakker G
    Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Dubois B; Opdenakker G; Carton H
    Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant epitopes, autoimmunity and glycosylation.
    Opdenakker G; Dillen C; Fiten P; Martens E; Van Aelst I; Van den Steen PE; Nelissen I; Starckx S; Descamps FJ; Hu J; Piccard H; Van Damme J; Wormald MR; Rudd PM; Dwek RA
    Biochim Biophys Acta; 2006 Apr; 1760(4):610-5. PubMed ID: 16439062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of gelatinase B/matrix metalloproteinase-9 activity comparison of a peptidomimetic and polyhistidine with single-chain derivatives of a neutralizing monoclonal antibody.
    Hu J; Van den Steen PE; Houde M; Ilenchuk TT; Opdenakker G
    Biochem Pharmacol; 2004 Mar; 67(5):1001-9. PubMed ID: 15104254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinase-9-Generated COOH-, but Not NH
    Gouwy M; De Buck M; Abouelasrar Salama S; Vandooren J; Knoops S; Pörtner N; Vanbrabant L; Berghmans N; Opdenakker G; Proost P; Van Damme J; Struyf S
    Front Immunol; 2018; 9():1081. PubMed ID: 29915572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia.
    Furuzawa-Carballeda J; Boon L; Torres-Villalobos G; Romero-Hernández F; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Coss-Adame E; Valdovinos M; Velazquez-Fernández D; Opdenakker G
    Clin Transl Gastroenterol; 2018 Nov; 9(11):208. PubMed ID: 30449890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
    Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
    FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
    Paemen L; Martens E; Masure S; Opdenakker G
    Eur J Biochem; 1995 Dec; 234(3):759-65. PubMed ID: 8575432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane.
    Delclaux C; Delacourt C; D'Ortho MP; Boyer V; Lafuma C; Harf A
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):288-95. PubMed ID: 8845180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
    Van den Steen PE; Proost P; Brand DD; Kang AH; Van Damme J; Opdenakker G
    Biochemistry; 2004 Aug; 43(33):10809-16. PubMed ID: 15311942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.
    Martens E; Leyssen A; Van Aelst I; Fiten P; Piccard H; Hu J; Descamps FJ; Van den Steen PE; Proost P; Van Damme J; Liuzzi GM; Riccio P; Polverini E; Opdenakker G
    Biochim Biophys Acta; 2007 Feb; 1770(2):178-86. PubMed ID: 17137715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).
    Van den Steen PE; Dubois B; Nelissen I; Rudd PM; Dwek RA; Opdenakker G
    Crit Rev Biochem Mol Biol; 2002 Dec; 37(6):375-536. PubMed ID: 12540195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    Ugarte-Berzal E; Berghmans N; Boon L; Martens E; Vandooren J; Cauwe B; Thijs G; Proost P; Van Damme J; Opdenakker G
    PLoS One; 2018; 13(10):e0197944. PubMed ID: 30273366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
    Van Den Steen PE; Wuyts A; Husson SJ; Proost P; Van Damme J; Opdenakker G
    Eur J Biochem; 2003 Sep; 270(18):3739-49. PubMed ID: 12950257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.
    Nelissen I; Martens E; Van den Steen PE; Proost P; Ronsse I; Opdenakker G
    Brain; 2003 Jun; 126(Pt 6):1371-81. PubMed ID: 12764058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and proteinases in autoimmune diseases and cancer.
    Opdenakker G; Van Damme J
    Verh K Acad Geneeskd Belg; 2002; 64(2):105-36. PubMed ID: 12085566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta.
    Bartholomé EJ; Van Aelst I; Koyen E; Kiss R; Willems F; Goldman M; Opdenakker G
    J Interferon Cytokine Res; 2001 Jul; 21(7):495-501. PubMed ID: 11506743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.